Pharmacies to shun quasi-drugs

Pharmaceutical business sources say that many pharmacies has little interest in handling quasi-drugs due to their concentrated efforts to acquire more prescriptions, while quasi-drug makers are also shunning the pharmacy market in fear of protracted settlement period, spoiled selling, and higher margin pressure.

Recently, a large-sized pharmaceutical firm launched a novel-concept, patch-typ...